Although kynurenine, kynurenic acid, and xanthurenic acid derived from indolamine dioxygenase (IDO) accumulate in CKD and may also activate AhR, studies indicate that kynurenine pathway metabolites have beneficial vascular effects via the orphan G protein–coupled receptor 35 (16). The gene discussed is IDO1; the disease is chronic kidney disease.